儿童寨卡病毒感染的年龄相关表现与病例定义评估
该研究在尼加拉瓜前瞻性儿童登革热队列中分析556例实验室确诊寨卡与548例非寨卡病例,发现WHO和PAHO病例定义主要捕获呈登革热样表现的较大龄患儿,而约三分之二以未分化发热或无热皮疹为主的病例被漏诊;病例定义敏感性随年龄增长而升高。
要点
- WHO与PAHO寨卡病例定义在儿童中敏感性低,且随年龄增长而升高。
- 约三分之二儿童寨卡病例表现为未分化发热或无热皮疹,被现行定义漏诊。
- 较小龄患儿多为未分化发热或无热皮疹,较大龄患儿更呈登革热样表现。
核心结论
- 现行WHO和PAHO寨卡病例定义漏诊多数儿童寨卡病例,病例确认标准需修订。
- 儿童寨卡临床表现轻微但随年龄不同,给诊断、监测和疫情控制带来挑战。
研究设计与样本
- 前瞻性队列研究,依托尼加拉瓜马那瓜儿童登革热队列研究(PDCS),覆盖2016年寨卡疫情主要时期。
- 共分析556例实验室确诊寨卡病例与548例非寨卡病例,受试儿童年龄2–14岁。
主要发现
- 寨卡病例中最常见为皮疹(n=440)、发热(n=333)、白细胞减少(n=217)和头痛(n=203),多在发病3天内达峰。
- 发病第一周最常见的寨卡表现为仅皮疹(n=80)。
- WHO定义捕获176例确诊寨卡病例,PAHO定义捕获109例,均为临床表现较多、呈登革热样者。
关键数值与推荐
- WHO病例定义敏感性随儿童年龄从11·3%升至56·1%,PAHO定义从6·0%升至36·6%。
- 多数临床表现(尤其关节痛)的患病率随年龄增长而升高,与既往登革病毒感染无关。
临床怎么用
- 在儿童中应用WHO或PAHO寨卡病例定义时需警惕漏诊,尤其对未分化发热或无热皮疹的较小龄患儿。
- 儿童寨卡诊断与监测应结合年龄相关表现差异,不能仅依赖现行病例定义。
局限性
- 原文摘要未报告本研究的具体局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Paedeatric Zika remains an understudied topic. WHO and the Pan American Health Organization (PAHO) Zika case definitions have not been assessed in children. We aimed to characterise clinical profiles and evaluate the diagnostic performance of the WHO and PAHO case definitions in a large cohort of paediatric Zika cases. METHODS: From January, 2016 to February, 2017, encompassing the major 2016 Zika epidemic, participants in the Pediatric Dengue Cohort Study (PDCS) in Managua, Nicaragua, were encouraged to visit the study health centre at first indication of any illness. PDCS participants were aged 2-14 years, healthy at enrolment, and recruited before the initiation of the present study. Molecular and serological assays were used to test participants exhibiting any of four broad clinical profiles suspected of resulting from a symptomatic Zika virus infection. These clinical profiles were: fever and at least two of headache, retro-orbital pain, myalgia, arthralgia, rash, haemorrhagic manifestations, and leukopenia; fever and at least two of nausea or vomiting, rash, aches and pains, positive tourniquet test, leukopenia, and any dengue warning sign; undifferentiated fever without evident cause, with or without any other clinical finding; and afebrile rash with or without any other clinical finding. We characterised acute clinical findings (signs, symptoms, and complete blood counts) in both Zika cases and non-Zika cases. FINDINGS: We prospectively followed a cohort of about 3700 children, of which 1110 were deemed eligible for inclusion. Four participants with laboratory-confirmed Zika (three co-infections with dengue virus, one missing complete blood count data) and two participants who were non-Zika cases (missing complete blood count data) were excluded from analysis. We analysed 556 laboratory-confirmed Zika and 548 non-Zika cases. The WHO case definition captured 176 confirmed Zika cases, and the PAHO definition 109 confirmed Zika cases, who presented with the most clinical findings and a dengue-like clinical profile. The remaining two thirds of Zika cases, principally characterised by undifferentiated fever or afebrile rash, were missed. Among Zika cases, rash (n=440)-particularly generalised erythematous rash (n=334)-fever (n=333), leukopenia (n=217), and headache (n=203) were most common and peaked within 3 days of illness onset. The most common Zika presentation over the first week of illness was rash only (n=80). The sensitivity of Zika case definitions increased across paediatric age (from 11·3% to 56·1% for the WHO case definition and from 6·0% to 36·6% for the PAHO case definition), as the prevalence of most clinical findings (particularly arthralgia) increased with age, irrespective of previous dengue virus infection. Consequently, Zika manifested differently across paediatric age; older Zika cases presented with a dengue-like clinical profile while younger Zika cases presented with undifferentiated fever or afebrile rash. INTERPRETATION: We provide the most thorough description of paediatric Zika to date. Most paediatric Zika cases go undetected under the WHO and PAHO case definitions, suggesting that current standards for Zika case ascertainment require revision. Zika manifests with mild but differing clinical profiles across paediatric age, presenting major challenges to diagnosis, surveillance, and efforts to control future Zika epidemics. FUNDING: US National Institutes of Health.
引用
- Burger-Calderon R, Bustos Carrillo F, Gresh L, et al. Age-dependent manifestations and case definitions of paediatric Zika: a prospective cohort study. Lancet Infect Dis. 2019. PMID: 31870907. doi:10.1016/S1473-3099(19)30547-X
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。